RecruitingNCT04216186
Study of coenzyme Q in children with ADHD
About this title
Read the official source — NCT04216186Medication studyAges 2–18Egypt
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 2 years to 18 years. Other eligibility criteria apply.
- Listed locations
- TantaSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 1, 2018
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Sherief Abd-Elsalam
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Egypt
- Age range
- From 2 Years to 18 Years
- Official registry ID
- NCT04216186
- Official title
Show the full official title
Role of Coenzyme Q in Treatment of Attention Deficit Hyperactivity Disorder in Children
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Tanta
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sherief Abd-Elsalam.
Does this study involve medication?
Yes. The study involves medication, including Atomoxetine and Coenzyme Q.
Who can participate?
This study is for people with ADHD. Listed age limits: 2 years to 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
